T
HERE IS considerable circumstantial evidence that hypertension is associated with abnormalities of water and electrolyte metabolism. In man this evidence rests mainly upon the fact that a low sodium diet will frequently reduce blood pressure's 2 and that salt-retaining hormones will produce hypertension.a A drug which lowers blood pressure by producing a pronounced and continued diuretic effect upon the kidney must, therefore, be of considerable interest.
Before such a drug could be regarded as affecting the disease process, however, it would be necessary to show that it acts by reducing peripheral resistance.
At first sight, chlorothiazide did not appear to fit this role since its hypotensive action was shown by Freis4 and Dustan to result from a loss of plasma volume and thereby a reduction in cardiac output. We made measurements similar to these but under different circumstances.
Our studies consisted in measurement of cardiac outputs of patients who had been taking chlorothiazide, 1 gm. per day, continuously for at least 1 month; whereas both Freis and Dustan determined their effects of chlorothiazide after periods of less than 2 weeks.
Cardiac Output:
In fifteen of nineteen patients in our series, the cardiac output was either unchanged or increased after chlorothiazide therapy.
Only four patients showed a decline in cardiac output.
The mean control cardiac index for this group prior to treatment was 3.7 L. per minute.
After treatment it was 4.1 L. per minute.
Since blood pressure was reduced at this time, the calculated peripheral resistance was also reduced by a mean of 23.6 per cent6 (Fig. 1) .
Plasma Volume and Perifheral Resistance: Since cardiac output is extremely variable even with every effort to standardize laboratory conditions, we placed considerable importance upon plasma volume determinations made under similar circumstances of treatment.
Here again, we were unable to demonstrate a physiologic difference.
In ten subjects we noted a mean reduction in plasma volume on only 90 m1.6 To satisfy ourselves that these results represented a true difference between the acute and chronic stages of treatment, the effects of plasma volume and cardiac output of short periods of chlorothiazide therapy were studied in seven patients. Plasma volume determinations in four patients showed a mean reduction of 401 ml. and cardiac index measurement in four 'patients showed a mean reduction of 1 L. per minute.
In this period, the fall in output was proportionately greater than the 'change in blood pressure; consequently, total peripheral resistance increased by a mean of 14.6 per cent (Fig. 2) .
It appeared, therefore, that there was a change in the mechanism between the acute and chronic stages of treatment with chlorothiazide. The nature of this change is unknown but it is gratifying to see that the early unphysiologic effect of the drug is replaced after a few weeks of therapy by one which produces reduction of peripheral resistance.
To suggest that this mechanism reverses the hypertensive process would be premature, but these findings suggest that chlorothiazide is worthy of more intensive study.
Sodium Depletion and Fall in Body Water: While the initial attention was thrown on the sodium-losing ability of chlorothiazide, it has not been shown that sodium depletion is the essential requirement for the hypotensive effect. Since we and others10 were unable to show a fall in extracellular fluid volume, we must conclude that this change in total body water represents a loss of intracellular water.
In seven patients studied by us, the mean reduction was 1.9 L. This corresponded with a fall in body weight of 1.4 kg.
It remains to be shown whether this change is the one responsible for the fall in blood pressure, but if chlorothiazide is affecting the hypotensive process, it would seem to us that the focus of attention should be on the distribution of body water in hypertension rather than upon sodium.
To be sure, these two parameters are closely linked and, like Siamese twins, special tricks will have to be devised to separate them.
Should loss of body water prove to be the essential change responsible for fall in blood pressure produced by chlorothiazide, the problem will remain to elucidate the mechanism by which the peripheral resistance is reduced. The effect on the blood vessels may be upon the contractility of smooth muscle, upon the structure of whole blood vessels as suggested by Tobian" or possibly by an external effect reducing tissue pressure which is exerted on the vascular tree throughout its length. These alternatives are under active investigation at the present time. 
SUMMARY
The possibility that chlorothiazide affects the hypertensive process is a very real one since the effect on the blood pressure of long term treatment is to reduce peripheral resistance.
The means by which this is achieved is unknown. It cannot be shown to be due to loss of sodium since the level of exchangeable sodium returns to normal on long term treatment. The only change we have been able to observe is a fall in total body water which is believed to be due to a loss of cellular water.
